Ki-67 to Predict Recurrence and Survival of Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Genc, C. [1 ]
Falconi, M. [2 ,3 ]
Partelli, S. [2 ,3 ]
Muffatti, F. [2 ,3 ]
Van Eeden, S. [1 ]
Doglioni, C. [2 ,3 ]
Klumpen, H. J. [1 ]
Van Eijck, C. [4 ]
Van Dijkum, Nieveen E. [1 ]
机构：
[1] Acad Med Ctr Amsterdam, Amsterdam, Netherlands
[2] San Rafaelle Hosp, Milan, Italy
[3] Univ Milan, Milan, Italy
[4] Erasmus MC, Rotterdam, Netherlands
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
neuroendocrine tumors; pancreas; recurrence; survival; ki-67 proliferation index; prognosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
D26
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [31] Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors
    Oberg, T. N.
    Voss, J. S.
    Lohse, C. M.
    Wu, T-T
    Smyrk, T. C.
    Zhang, L.
    MODERN PATHOLOGY, 2012, 25 : 447A - 448A
  • [32] Ki-67 is a reliable pathological grading marker for neuroendocrine tumors
    Ashlie Nadler
    Moises Cukier
    Corwyn Rowsell
    Sepideh Kamali
    Yael Feinberg
    Simron Singh
    Calvin H. L. Law
    Virchows Archiv, 2013, 462 : 501 - 505
  • [33] Comparison of Manual and Digital Assessment of KI-67 in Neuroendocrine Tumors
    Raju, B. S.
    Quinton, M.
    Hassell, L.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S125 - S125
  • [34] Predicting Prognosis in Gastroentero-Pancreatic Neuroendocrine Tumors: An Overview and the Value of Ki-67 Immunostaining
    Mina Jamali
    Runjan Chetty
    Endocrine Pathology, 2008, 19
  • [35] Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors
    Kroneman, Trynda N.
    Voss, Jesse S.
    Lohse, Christine M.
    Wu, Tsung-Teh
    Smyrk, Thomas C.
    Zhang, Lizhi
    ENDOCRINE PATHOLOGY, 2015, 26 (03) : 255 - 262
  • [36] Can Ki-67 with 5.5% Be Better in Predicting Prognosis for Well Differentiated Pancreatic Neuroendocrine Tumors?
    Yuan, B.
    Chen, Y. Y.
    Zhang, P.
    Wang, X.
    Tan, H. D.
    Li, Y.
    Qi, Z.
    Luo, J.
    Yang, Z. Y.
    Tan, H. Y.
    NEUROENDOCRINOLOGY, 2020, 110 : 131 - 131
  • [37] Quantification of Ki-67 in PitNET (pituitary neuroendocrine tumors)/adenomas
    Klein, Judith
    Saeger, Kai
    Saeger, Wolfgang
    PATHOLOGIE, 2024, 45 (05): : 339 - 343
  • [38] Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors
    Oberg, T. N.
    Voss, J. S.
    Lohse, C. M.
    Wu, T-T
    Smyrk, T. C.
    Zhang, L.
    LABORATORY INVESTIGATION, 2012, 92 : 447A - 448A
  • [39] Alternative lengthening of telomeres and Ki-67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors
    Gudmundsdottir, Hallbera
    Graham, Rondell P.
    Greipp, Patricia T.
    Habermann, Elizabeth B.
    Knudson, Ryan A.
    Brandt, Carrie A.
    Starlinger, Patrick
    Thiels, Cornelius A.
    Warner, Susanne G.
    Smoot, Rory L.
    Truty, Mark J.
    Kendrick, Michael L.
    Nagorney, David M.
    Cleary, Sean P.
    Halfdanarson, Thorvardur R.
    JOURNAL OF NEUROENDOCRINOLOGY, 2025,
  • [40] Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease
    Alexandra G. Lopez-Aguiar
    Cecilia G. Ethun
    Lauren M. Postlewait
    Kristen Zhelnin
    Alyssa Krasinskas
    Bassel F. El-Rayes
    Maria C. Russell
    Juan M. Sarmiento
    David A. Kooby
    Charles A. Staley
    Shishir K. Maithel
    Kenneth Cardona
    Annals of Surgical Oncology, 2018, 25 : 290 - 298
12345